US FDA places Import Alert on Sun Pharmaceutical Plant

Shanghvi.jpg

Sun Pharmaceutical Industries Limited, the largest drug maker in India in terms of market value, witnessed a fall in its share price due to an import alert placed on the company by the FDA in the United States. These import restrictions to the United States have been attributed due to non-adherence of manufacturing guidelines in one plant.
 

read more